Chemoinformaics analysis of 2-Methylpentadecane
Molecular Weight | 226.448 | nRot | 12 |
Heavy Atom Molecular Weight | 192.176 | nRig | 12 |
Exact Molecular Weight | 226.266 | nRing | 0 |
Solubility: LogS | -5.06 | nHRing | 0 |
Solubility: LogP | 4.325 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 49.391 |
nHD | 0 | BPOL | 34.109 |
QED | 0.473 |
Synth | 4.207 |
Natural Product Likeliness | 1.555 |
NR-PPAR-gamma | 0.852 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.997 |
Pgp-sub | 0.005 |
HIA | 0.005 |
CACO-2 | -4.554 |
MDCK | 0.0000208 |
BBB | 0.053 |
PPB | 0.890577 |
VDSS | 0.677 |
FU | 0.112399 |
CYP1A2-inh | 0.667 |
CYP1A2-sub | 0.552 |
CYP2c19-inh | 0.948 |
CYP2c19-sub | 0.779 |
CYP2c9-inh | 0.887 |
CYP2c9-sub | 0.162 |
CYP2d6-inh | 0.549 |
CYP2d6-sub | 0.168 |
CYP3a4-inh | 0.91 |
CYP3a4-sub | 0.613 |
CL | 8.722 |
T12 | 0.156 |
hERG | 0.002 |
Ames | 0.031 |
ROA | 0.406 |
SkinSen | 0.608 |
Carcinogencity | 0.851 |
EI | 0.024 |
Respiratory | 0.867 |
NR-Aromatase | 0.703 |
Antiviral | Yes |
Prediction | 0.674078 |